PRCT - PROCEPT BioRobotics Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$42.40
DETAILS
HIGH:
$62.00
LOW:
$30.00
MEDIAN:
$35.00
CONSENSUS:
$42.40
UPSIDE:
52.22%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 308.1 | 224.5 | 136.2 | 75.0 | 34.5 | 7.7 | 6.2 |
| Cost of Revenue | 111.8 | 87.4 | 65.1 | 37.9 | 18.6 | 9.0 | 8.1 |
| Gross Profit | 196.2 | 137.1 | 71.0 | 37.1 | 15.9 | (1.3) | (1.9) |
| Operating Expenses | |||||||
| R&D Expenses | 71.3 | 62.3 | 48.4 | 29.0 | 19.0 | 16.3 | 13.1 |
| SG&A Expenses | 228.8 | 171.4 | 131.8 | 88.8 | 51.0 | 30.3 | 28.5 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 300.1 | 233.7 | 180.2 | 117.8 | 70.0 | 46.5 | 41.7 |
| Operating Income | |||||||
| Operating Income | (103.9) | (96.6) | (109.2) | (80.7) | (54.2) | (47.8) | (43.5) |
| Interest Expense | 3.6 | 4.2 | 4.0 | 5.2 | 5.8 | 5.3 | 0.7 |
| Interest Income | 12.2 | 10.9 | 7.6 | 2.5 | 0.1 | 0.2 | 1.1 |
| Profitability | |||||||
| EBITDA | (97.5) | (82.0) | (98.1) | (79.1) | (50.7) | (44.9) | (39.8) |
| EBIT | (103.9) | (87.2) | (101.9) | (82.0) | (54.0) | (47.8) | (41.3) |
| Income Before Tax | (95.4) | (91.4) | (105.9) | (87.2) | (59.9) | (53.0) | (42.0) |
| Income Tax Expense | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (95.6) | (91.4) | (105.9) | (87.2) | (59.9) | (53.0) | (42.0) |
| Per Share Data | |||||||
| EPS (Basic) | -1.72 | -1.75 | -2.24 | -1.96 | -1.37 | -1.51 | -1.25 |
| EPS (Diluted) | -1.72 | -1.75 | -2.24 | -1.96 | -1.37 | -1.51 | -1.25 |
| Shares Outstanding | 55.5 | 52.1 | 47.3 | 44.4 | 43.7 | 35.1 | 33.6 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 286.5 | 333.7 | 257.2 | 222.6 | 304.3 | 100.1 | 42.0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 83.5 | 83.5 | 48.4 | 15.3 | 4.5 | 1.5 | 1.1 |
| Inventory | 70.7 | 56.2 | 39.8 | 28.5 | 13.1 | 7.5 | 6.7 |
| Other Current Assets | 9.6 | 8.5 | 5.2 | 6.2 | 3.4 | 0 | 0 |
| Total Current Assets | 450.4 | 481.8 | 350.6 | 272.6 | 326.2 | 109.9 | 50.4 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 47.9 | 45.6 | 49.0 | 32.1 | 8.3 | 12.9 | 8.3 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0.7 | 0.9 | 1.2 | 1.5 | 1.8 | 2.0 | 2.3 |
| Long-Term Investments | 0 | 3.0 | 3.0 | 3.0 | 0.8 | 0.8 | 0.7 |
| Other Non-Current Assets | 9.1 | 2.6 | 0.9 | 0.1 | 0 | 0.4 | 0.4 |
| Total Non-Current Assets | 57.7 | 52.2 | 54.1 | 36.7 | 10.9 | 16.1 | 11.6 |
| Total Assets | 508.1 | 534.0 | 404.7 | 309.3 | 337.0 | 126.0 | 62.0 |
| Current Liabilities | |||||||
| Account Payables | 17.3 | 10.0 | 13.5 | 9.4 | 2.0 | 1.2 | 1.4 |
| Short-Term Debt | 0 | 1.9 | 1.7 | 2.1 | 2.1 | 6.3 | 0 |
| Deferred Revenue | 13.0 | 9.6 | 5.7 | 2.9 | 1.0 | 0.2 | 0.1 |
| Other Current Liabilities | 35.5 | 10.1 | 8.2 | 7.5 | 4.6 | 2.2 | 2.9 |
| Total Current Liabilities | 65.8 | 53.1 | 45.9 | 35.3 | 16.2 | 14.5 | 6.8 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 51.6 | 51.5 | 51.3 | 51.2 | 50.0 | 44.4 | 23.2 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 24.8 | 0.3 | 0.5 | 1.8 | 1.7 | 2.0 | 2.8 |
| Total Non-Current Liabilities | 76.4 | 78.7 | 78.0 | 77.0 | 53.7 | 50.5 | 26.0 |
| Total Liabilities | 142.2 | 131.8 | 124.0 | 112.3 | 69.9 | 65.0 | 32.8 |
| Stockholders' Equity | |||||||
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (641.6) | (546.0) | (454.6) | (348.7) | (261.5) | (201.7) | (148.6) |
| Accumulated Other Comprehensive Income | 0 | 0.1 | 0.1 | (0.0) | (0.1) | (0.0) | 0.0 |
| Total Stockholders' Equity | 365.9 | 402.2 | 280.8 | 197.1 | 267.1 | 61.0 | 29.2 |
| Total Liabilities & Equity | 508.1 | 534.0 | 404.7 | 309.3 | 337.0 | 126.0 | 62.0 |
| Debt Metrics | |||||||
| Total Debt | 51.6 | 80.2 | 79.2 | 77.3 | 54.1 | 54.8 | 23.2 |
| Net Debt | (234.9) | (253.5) | (178.0) | (145.3) | (250.2) | (45.4) | (18.8) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (95.6) | (91.4) | (105.9) | (87.2) | (59.9) | (53.0) | (42.0) |
| Depreciation & Amortization | 6.4 | 5.2 | 3.8 | 2.8 | 3.3 | 2.9 | 1.5 |
| Stock-Based Compensation | 47.6 | 31.8 | 19.1 | 10.3 | 3.8 | 2.2 | 2.0 |
| Change in Working Capital | (7.8) | (47.3) | (26.2) | (11.5) | (4.7) | (0.5) | (3.5) |
| Other Non-Cash Items | 0.4 | 2.5 | 1.1 | 5.1 | (0.3) | 0.1 | (1.8) |
| Operating Cash Flow | (49.0) | (99.2) | (108.0) | (80.4) | (57.3) | (48.3) | (43.8) |
| Investing Activities | |||||||
| Capital Expenditure | (9.4) | (4.4) | (25.2) | (2.7) | (0.6) | (0.2) | (7.6) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 50.8 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (9.4) | (4.4) | (25.2) | (2.7) | (0.6) | (0.2) | 43.2 |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | 0 | 0 | 1.2 | 0 | 24.7 | 24.5 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 15.6 | 6.1 | 2.4 | 5.0 | 5.6 | 2.0 |
| Financing Cash Flow | 11.2 | 180.1 | 167.8 | 3.6 | 262.1 | 106.8 | 26.5 |
| Cash Position | |||||||
| Net Change in Cash | (47.2) | 76.5 | 34.6 | (79.4) | 204.2 | 58.2 | 25.9 |
| Cash at Beginning | 336.8 | 260.3 | 225.7 | 305.1 | 100.9 | 42.7 | 16.9 |
| Cash at End | 289.5 | 336.8 | 260.3 | 225.7 | 305.1 | 100.9 | 42.7 |
| Free Cash Flow | (58.3) | (103.6) | (133.2) | (83.0) | (57.9) | (48.6) | (51.4) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 308.1 | 224.5 | 136.2 | 75.0 | 34.5 | 7.7 | 6.2 |
| Gross Profit | 196.2 | 137.1 | 71.0 | 37.1 | 15.9 | (1.3) | (1.9) |
| Operating Income | (103.9) | (96.6) | (109.2) | (80.7) | (54.2) | (47.8) | (43.5) |
| Net Income | (95.6) | (91.4) | (105.9) | (87.2) | (59.9) | (53.0) | (42.0) |
| EPS (Diluted) | -1.72 | -1.75 | -2.24 | -1.96 | -1.37 | -1.51 | -1.25 |
| Balance Sheet | |||||||
| Cash & Equivalents | 286.5 | 333.7 | 257.2 | 222.6 | 304.3 | 100.1 | 42.0 |
| Total Assets | 508.1 | 534.0 | 404.7 | 309.3 | 337.0 | 126.0 | 62.0 |
| Total Debt | 51.6 | 80.2 | 79.2 | 77.3 | 54.1 | 54.8 | 23.2 |
| Stockholders' Equity | 365.9 | 402.2 | 280.8 | 197.1 | 267.1 | 61.0 | 29.2 |
| Cash Flow | |||||||
| Operating Cash Flow | (49.0) | (99.2) | (108.0) | (80.4) | (57.3) | (48.3) | (43.8) |
| Capital Expenditure | (9.4) | (4.4) | (25.2) | (2.7) | (0.6) | (0.2) | (7.6) |
| Free Cash Flow | (58.3) | (103.6) | (133.2) | (83.0) | (57.9) | (48.6) | (51.4) |